A novel method of modifying immune responses by vaccination with lipiodol-siRNA mixtures

Journal of Translational Medicine

Volumn 4, Issue , 2006, Pages

  Ichim, Thomas E ^a   Popov, Igor A ^b   Riordan, Neil H ^a   Izadi, Hamid ^a   Zhong, Zhaohui ^c   Li, Yijian ^c   Sher, Salman ^d   Oleinik, Eugenia K ^e  

^a MediStem Laboratories Inc   (United States)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c CENTRAL SOUTH UNIVERSITY   (China)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e INSTITUTE OF BIOLOGY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P35; INTERLEUKIN 4; IODINATED POPPYSEED OIL; OVALBUMIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AUTOIMMUNE DISEASE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIABETES MELLITUS; DNA MODIFICATION; DRUG TARGETING; FEMALE; GENE TARGETING; GENETIC TRANSFECTION; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; TH1 CELL; TH2 CELL; VACCINATION;

EID: 30544443033     PISSN: 14795876     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-4-2     Document Type: Article

References (50)

1. Mosmann, T.R., Cherwinski, H., Bond, M.W., Giedlin, M.A., and Coffman, R.L. 1986. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136:2348-2357.
2. Mosmann, T.R., and Coffman, R.L. 1989. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7:145-173.
3. Singh, V.K., Mehrotra, S., and Agarwal, S.S. 1999. The paradigm of Th1 and Th2 cytokines: its relevance to autoimmunity and allergy. Immunol Res 20:147-161.
4. Sospedra, M., and Martin, R. 2004. Immunology of Multiple Sclerosis. Annu Rev Immunol.
5. Miossec, P., and van den Berg, W. 1997. Th1/Th2 cytokine balance in arthritis. Arthritis Rheum 40:2105-2115.
6. Dabbagh, K., and Lewis, D.B. 2003. Toll-like receptors and T-helper-1/ T-helper-2 responses. Curr Opin Infect Dis 16:199-204.
7. Steinman, R.M. 2003. The control of immunity and tolerance by dendritic cell. Pathol Biol (Paris) 51:59-60.
8. Agrawal, S., Agrawal, A., Doughty, B., Gerwitz, A., Blenis, J., Van Dyke, T., and Pulendran, B. 2003. Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos. J Immunol 171:4984-4989.
9. Redecke, V., Hacker, H., Datta, S.K., Fermin, A., Pitha, P.M., Broide, D.H., and Raz, E. 2004. Cutting edge: activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma. J Immunol 172:2739-2743.
10. Mazzoni, A., and Segal, D.M. 2004. Controlling the Toll road to dendritic cell polarization. J Leukoc Biol 75:721-730.
11. Papaccio, G., Nicoletti, F., Pisanti, F.A., Bendtzen, K., and Galdieri, M. 2000. Prevention of spontaneous autoimmune diabetes in NOD mice by transferring in vitro antigen-pulsed syngeneic dendritic cells. Endocrinology 141:1500-1505.
12. Feili-Hariri, M., Dong, X., Alber, S.M., Watkins, S.C., Salter, R.D., and Morel, P.A. 1999. Immunotherapy of NOD mice with bone marrow-derived dendritic cells. Diabetes 48:2300-2308.
13. Morita, Y., Yang, J., Gupta, R., Shimizu, K., Shelden, E.A., Endres, J., Mule, J.J., McDonagh, K.T., and Fox, D.A. 2001. Dendritic cells genetically engineered to express IL-4 inhibit murine collagen-induced arthritis. J Clin Invest 107:1275-1284.
14. Link, H., Huang, Y.M., Masterman, T., and Xiao, B.G. 2001. Vaccination with autologous dendritic cells: from experimental autoimmune encephalomyelitis to multiple sclerosis. J Neuroimmunol 114:1-7.
15. Yang, J.S., Xu, L.Y., Huang, Y.M., Van Der Meide, P.H., Link, H., and Xiao, B.G. 2000. Adherent dendritic cells expressing high levels of interleukin-10 and low levels of interleukin- 12 induce antigen-specific tolerance to experimental autoimmune encephalomyelitis. Immunology 101:397-403.
16. Tang, G. 2005. siRNA and miRNA: an insight into RISCs. Trends Biochem Sci 30:106-114.
17. Elbashir, S.M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., and Tuschl, T. 2001. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411:494-498.
18. Liu, G., Ng, H., Akasaki, Y., Yuan, X., Ehtesham, M., Yin, D., Black, K.L., and Yu, J.S. 2004. Small interference RNA modulation of IL-10 in human monocyte-derived dendritic cells enhances the Th1 response. Eur J Immunol 34:1680-1687.
19. Hill, J.A., Ichim, T.E., Kusznieruk, K.P., Li, M., Huang, X., Yan, X., Zhong, R., Cairns, E., Bell, D.A., and Min, W.P. 2003. Immune modulation by silencing IL-12 production in dendritic cells using small interfering RNA. J Immunol 171:691-696.
20. Flynn, M.A., Casey, D.G., Todryk, S.M., and Mahon, B.P. 2004. Efficient delivery of small interfering RNA for inhibition of IL-12p40 expression in vivo. J Inflamm (Lond) 1:4.
21. Lovett-Racke, A.E., Rocchini, A.E., Choy, J., Northrop, S.C., Hussain, R.Z., Ratts, R.B., Sikder, D., and Racke, M.K. 2004. Silencing T-bet defines a critical role in the differentiation of autoreactive T lymphocytes. Immunity 21:719-731.
22. Kobayashi, T., and Yoshimura, A. 2005. Keeping DCs awake by putting SOCS1 to sleep. Trends Immunol 26:177-179.
23. Li, M., Qian, H., Ichim, T.E., Ge, W.W., Popov, I.A., Rycerz, K., Neu, J., White, D., Zhong, R., and Min, W.P. 2004. Induction of RNA interference in dendritic cells. Immunol Res 30:215-230.
24. Ichim, T.E., Li, M., Qian, H., Popov, I.A., Rycerz, K., Zheng, X., White, D., Zhong, R., and Min, W.P. 2004. RNA interference: a potent tool for gene-specific therapeutics. Am J Transplant 4:1227-1236.
25. Klein, C., Bock, C.T., Wedemeyer, H., Wustefeld, T., Locarnini, S., Dienes, H.P., Kubicka, S., Manns, M.P., and Trautwein, C. 2003. Inhibition of hepatitis B virus replication in vivo by nucleoside analogues and siRNA. Gastroenterology 125:9-18.
26. Contreras, J.L., Vilatoba, M., Eckstein, C., Bilbao, G., Anthony Thompson, J., and Eckhoff, D.E. 2004. Caspase-8 and caspase-3 small interfering RNA decreases ischemia/reperfusion injury to the liver in mice. Surgery 136:390-400.
27. Ichim, T.E., Zhong, R., and Min, W.P. 2003. Prevention of allograft rejection by in vitro generated tolerogenic dendritic cells. Transpl Immunol 11:295-306.
28. Bhattacharya, S., Dhillon, A.P., Winslet, M.C., Davidson, B.R., Shukla, N., Gupta, S.D., Al-Mufti, R., and Hobbs, K.E. 1996. Human liver cancer cells and endothelial cells incorporate iodised oil. Br J Cancer 73:877-881.
29. Romagnani, S. 1999. Th1/Th2 cells. Inflamm Bowel Dis 5:285-294.
30. Horwitz, D.A., Zheng, S.G., and Gray, J.D. 2003. The role of the combination of IL-2 and TGF-beta or IL-10 in the generation and function of CD4+ CD25+ and CD8+ regulatory T cell subsets. J Leukoc Biol 74:471-478.
31. Levings, M.K., Gregori, S., Tresoldi, E., Cazzaniga, S., Bonini, C., and Roncarolo, M.G. 2005. Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells. Blood 105:1162-1169.
32. Corinti, S., Albanesi, C., la Sala, A., Pastore, S., and Girolomoni, G. 2001. Regulatory activity of autocrine IL-10 on dendritic cell functions. J Immunol 166:4312-4318.
33. Serra, P., Amrani, A., Yamanouchi, J., Han, B., Thiessen, S., Utsugi, T., Verdaguer, J., and Santamaria, P. 2003. CD40 ligation releases immature dendritic cells from the control of regulatory CD4+CD25+ T cells. Immunity 19:877-889.
34. Ohshima, Y., Tanaka, Y., Tozawa, H., Takahashi, Y., Maliszewski, C., and Delespesse, G. 1997. Expression and function of OX40 ligand on human dendritic cells. J Immunol 159:3838-3848.
35. Nakahara, T., Urabe, K., Fukagawa, S., Uchi, H., Inaba, K., Furue, M., and Moroi, Y. 2005. Engagement of human monocyte-derived dendritic cells into interleukin (IL)-12 producers by IL-1beta + interferon (IFN)-gamma. Clin Exp Immunol 139:476-482.
36. Walsh, M.C., and Choi, Y. 2003. Biology of the TRANCE axis. Cytokine Growth Factor Rev 14:251-263.
37. Caux, C., Massacrier, C., Vanbervliet, B., Dubois, B., Van Kooten, C., Durand, I., and Banchereau, J. 1994. Activation of human dendritic cells through CD40 cross-linking. J Exp Med 180:1263-1272.
38. De Smedt, T., Van Mechelen, M., De Becker, G., Urbain, J., Leo, O., and Moser, M. 1997. Effect of interleukin-10 on dendritic cell maturation and function. Eur J Immunol 27:1229-1235.
39. He, Q., Moore, T.T., Eko, F.O., Lyn, D., Ananaba, G.A., Martin, A., Singh, S., James, L., Stiles, J., Black, C.M., et al. 2005. Molecular basis for the potency of IL-10-deficient dendritic cells as a highly efficient APC system for activating Th1 response. J Immunol 174:4860-4869.
40. Vogl, T.J., Wetter, A., Lindemayr, S., and Zangos, S. 2005. Treatment of unresectable lung metastases with transpulmonary chemoembolization: preliminary experience. Radiology 234:917-922.
41. Di Stefano, D.R., de Baere, T., Denys, A., Hakime, A., Gorin, G., Gillet, M., Saric, J., Trillaud, H., Petit, P., Bartoli, J.M., et al. 2005. Preoperative percutaneous portal vein embolization: evaluation of adverse events in 188 patients. Radiology 234:625-630.
42. Hamm, B., and Wolf, K.J. 1991. Contrast material for computed tomography and magnetic resonance imaging of the gastrointestinal tract. Curr Opin Radiol 3:474-482.
43. Bhattacharya, S., Novell, J.R., Winslet, M.C., and Hobbs, K.E. 1994. Iodized oil in the treatment of hepatocellular carcinoma. Br J Surg 81:1563-1571.
44. Rowbottom, A.W., Lepper, M.A., Garland, R.J., Cox, C.V., and Corley, E.G. 1999. Interleukin-10-induced CD8 cell proliferation. Immunology 98:80-89.
45. Akdis, C.A., and Blaser, K. 2001. Role of IL-10 in allergen-specific immunotherapy and normal response to allergens. Microbes Infect 3:891-898.
46. Hwang, E.S., Szabo, S.J., Schwartzberg, P.L., and Glimcher, L.H. 2005. T helper cell fate specified by kinase-mediated interaction of T-bet with GATA-3. Science 307:430-433.
47. Rothermel, A.L., Wang, Y., Schechner, J., Mook-Kanamori, B., Aird, W.C., Pober, J.S., Tellides, G., and Johnson, D.R. 2004. Endothelial cells present antigens in vivo. BMC Immunol 5:5.
48. Bourdoulous, S., Beraud, E., Le Page, C., Zamora, A., Ferry, A., Bernard, D., Strosberg, A.D., and Couraud, P.O. 1995. Anergy induction in encephalitogenic T cells by brain microvessel endothelial cells is inhibited by interleukin-1. Eur J Immunol 25:1176-1183.
49. Modolell, M., Corraliza, I.M., Link, F., Soler, G., and Eichmann, K. 1995. Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow-derived macrophages by TH1 and TH2 cytokines. Eur J Immunol 25:1101-1104.
50. den Brok, M.H., Sutmuller, R.P., van der Voort, R., Bennink, E.J., Figdor, C.G., Ruers, T.J., and Adema, G.J. 2004. In situ tumor ablation creates an antigen source for the generation of antitumor immunity. Cancer Res 64:4024-4029.